BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26294697)

  • 21. [Clinical significance of peak body temperature, white blood cell count, and C-reactive protein level in febrile episodes among geriatric inpatients].
    Ikematsu H; Nabeshima A; Yamaga S; Yamaji K; Kakuda K; Ueno K; Hayashi J; Shirai T; Hara H; Kashiwagi S
    Kansenshogaku Zasshi; 1997 Jun; 71(6):527-33. PubMed ID: 9248269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.
    Aarsland D; Litvan I; Salmon D; Galasko D; Wentzel-Larsen T; Larsen JP
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1215-20. PubMed ID: 12933921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reaction to a dementia diagnosis in individuals with Alzheimer's disease and mild cognitive impairment.
    Carpenter BD; Xiong C; Porensky EK; Lee MM; Brown PJ; Coats M; Johnson D; Morris JC
    J Am Geriatr Soc; 2008 Mar; 56(3):405-12. PubMed ID: 18194228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and psychosocial predictors of psychiatric emergency center transport and length of stay in patients with dementia and Alzheimer's disease: a preliminary report.
    Nejtek VA; Hardy S; Hall JR; Winter AS
    J Psychiatr Pract; 2011 Jul; 17(4):251-7. PubMed ID: 21775826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of febrile patients with normal white blood cell counts and high C-reactive protein levels in an emergency department.
    Liu KT; Lin TJ; Chan HM
    Kaohsiung J Med Sci; 2008 May; 24(5):248-53. PubMed ID: 18508422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of dementia screening tests with biomarkers of Alzheimer's disease.
    Galvin JE; Fagan AM; Holtzman DM; Mintun MA; Morris JC
    Brain; 2010 Nov; 133(11):3290-300. PubMed ID: 20823087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depression in dementia of the Alzheimer type and in multi-infarct dementia.
    Fischer P; Simanyi M; Danielczyk W
    Am J Psychiatry; 1990 Nov; 147(11):1484-7. PubMed ID: 2221160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in peripheral oxidative stress markers in Alzheimer's disease, vascular dementia and mixed dementia patients.
    Hatanaka H; Hanyu H; Fukasawa R; Hirao K; Shimizu S; Kanetaka H; Iwamoto T
    Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():53-8. PubMed ID: 26671158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study.
    O'Bryant SE; Waring SC; Cullum CM; Hall J; Lacritz L; Massman PJ; Lupo PJ; Reisch JS; Doody R;
    Arch Neurol; 2008 Aug; 65(8):1091-5. PubMed ID: 18695059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
    Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
    J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sialic acid, homocysteine and CRP: potential markers for dementia.
    Davis G; Baboolal N; Nayak S; McRae A
    Neurosci Lett; 2009 Nov; 465(3):282-4. PubMed ID: 19766699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of a Standardized and Specific Follow-Up in Memory Centers in Patients with Alzheimer's Disease.
    Rouch L; Cestac P; Cool C; Helmer C; Dartigues JF; Berr C; Rouaud O; Vellas B; Andrieu S;
    Curr Alzheimer Res; 2017; 14(3):255-267. PubMed ID: 27829336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of Homocysteine Plasma Levels with Mild Cognitive Impairment, Alzheimer's Disease, Vascular Dementia, Psychobehavioral, and Functional Complications.
    Lauriola M; D'Onofrio G; Ciccone F; Germano C; Cascavilla L; Paris F; Greco A
    J Alzheimers Dis; 2021; 82(1):235-248. PubMed ID: 34057086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional assessment staging (FAST) in Korean patients with Alzheimer's disease.
    Na HR; Kim SY; Chang YH; Park MH; Cho ST; Han IW; Kim TY; Hwang SA
    J Alzheimers Dis; 2010; 22(1):151-8. PubMed ID: 20847407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidimensional approach usefulness in early Alzheimer's disease: Advances in clinical practice.
    Pruneti C; Innocenti A; Cammisuli DM
    Acta Biomed; 2018 Mar; 89(1):79-86. PubMed ID: 29633747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of symptoms on the CERAD behavior rating scale for dementia in normal elderly subjects and Alzheimer's disease patients.
    Tractenberg RE; Patterson M; Weiner MF; Teri L; Grundman M; Thomas RG; Thal LJ
    J Neuropsychiatry Clin Neurosci; 2000; 12(4):472-9. PubMed ID: 11083164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of family caregiver ratings of patient quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study.
    Naglie G; Hogan DB; Krahn M; Black SE; Beattie BL; Patterson C; Macknight C; Freedman M; Borrie M; Byszewski A; Bergman H; Streiner D; Irvine J; Ritvo P; Comrie J; Kowgier M; Tomlinson G
    Am J Geriatr Psychiatry; 2011 Oct; 19(10):891-901. PubMed ID: 21946805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is Salivary Chromogranin A a Valid Psychological Stress Biomarker During Sensory Stimulation in People with Advanced Dementia?
    Valdiglesias V; Maseda A; Lorenzo-López L; Pásaro E; Millán-Calenti JC; Laffon B
    J Alzheimers Dis; 2017; 55(4):1509-1517. PubMed ID: 27886013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Comparison of Behavioral and Psychological Symptoms of Dementia (BPSD) and BPSD Sub-Syndromes in Early-Onset and Late-Onset Alzheimer's Disease.
    Altomari N; Bruno F; Laganà V; Smirne N; Colao R; Curcio S; Di Lorenzo R; Frangipane F; Maletta R; Puccio G; Bruni AC
    J Alzheimers Dis; 2022; 85(2):691-699. PubMed ID: 34864668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.